The Impact of Longitudinal Surveillance on Tumor Thickness for Melanoma-Prone Families with and without Pathogenic Germline Variants of CDKN2A and CDK4.
Michael R SargenRuth M PfeifferDavid E ElderXiaohong R YangAlisa M GoldsteinMargaret A TuckerPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2022)
The study findings support the clinical benefit of screening (physician and self) for this high-risk population.